118 related articles for article (PubMed ID: 9712456)
1. Secondary treatment failure without anti-human chorionic gonadotropin antibody in a patient with Kallmann syndrome.
Kitahara S; Yoshida K; Ishizaka K; Higashi Y; Takagi K; Oshima H
Int J Urol; 1998 Jul; 5(4):398-400. PubMed ID: 9712456
[TBL] [Abstract][Full Text] [Related]
2. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma luteinizing hormone, testosterone and estradiol-17 beta levels and semen quality after injections of gonadotropin releasing hormone agonist and human chorionic gonadotropin in three dogs with oligozoospermia and two dogs with azoospermia.
Kawakami E; Hori T; Tsutsui T
Anim Reprod Sci; 1997 May; 47(1-2):157-67. PubMed ID: 9233515
[TBL] [Abstract][Full Text] [Related]
4. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
5. [A case of Kallmann syndrome treated with gonadotropin (HCG/HMG) and gained fertility--comparative study with LH-RH interval injection therapy].
Okamoto S; Mimura M; Izumi Y; Hosokawa A; Fukui H; Tsujii T; Sanba S; Hirao Y; Okajima E
Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2072-4. PubMed ID: 8586932
[No Abstract] [Full Text] [Related]
6. Preservation of fertility despite subnormal gonadotropin and testosterone levels after cessation of pulsatile gonadotropin-releasing hormone therapy in a man with Kallmann's syndrome.
Bagatell CJ; Paulsen CA; Bremner WJ
Fertil Steril; 1994 Feb; 61(2):392-4. PubMed ID: 8299803
[TBL] [Abstract][Full Text] [Related]
7. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and MRI findings of Kallmann's syndrome.
Dash PK; Raj DH
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25498112
[TBL] [Abstract][Full Text] [Related]
10. [A case of Kallmann syndrome: usefulness of the aging male's symptoms rating scale for assessment of subjective symptoms].
Suetomi T; Inai H; Manabe F; Shimazui T; Akaza H
Hinyokika Kiyo; 2006 Aug; 52(8):661-5. PubMed ID: 16972633
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (LH-RH) and human chorionic gonadotropin in the treatment of two boys with hypogonadotrophic hypogonadism.
Krabbe S; Skakkebaek NE
Acta Paediatr Scand; 1977 May; 66(3):361-5. PubMed ID: 325993
[TBL] [Abstract][Full Text] [Related]
12. Acquired hypogonadotropic hypogonadism presenting as decreased seminal volume.
Tash JA; McGovern JH; Schlegel PN
Urology; 2000 Oct; 56(4):669. PubMed ID: 11019338
[TBL] [Abstract][Full Text] [Related]
13. [A case of Kallmann syndrome: diagnostic usefulness of cranial magnetic resonance imaging].
Shiraishi K; Naito K
Hinyokika Kiyo; 2000 Jul; 46(7):509-12. PubMed ID: 10965462
[TBL] [Abstract][Full Text] [Related]
14. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
15. Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy.
Yoshimura K; Nakashima Y; Sugiyama K; Kohei N; Takizawa A
Int Braz J Urol; 2019; 45(1):38-44. PubMed ID: 29757577
[TBL] [Abstract][Full Text] [Related]
16. A prospective pilot study of co-treatment with growth hormone and gonadotropins for improving spermatogenesis in normogonadotropic patients with severe oligoteratoasthenospermia.
Zalel Y; Draysen E; Goldschmit R; Zadik Z; Shoham Z
Gynecol Endocrinol; 1996 Feb; 10(1):23-8. PubMed ID: 8737188
[TBL] [Abstract][Full Text] [Related]
17. Patterns of serum FSH, LH and hCG after i.m. or i.v. administration of hMG during pituitary suppression.
Duijkers IJ; Hollanders HM; Willemsen WN; de Leeuw R; Vemer HM
Int J Fertil Menopausal Stud; 1995; 40(2):86-91. PubMed ID: 7599664
[TBL] [Abstract][Full Text] [Related]
18. Initiation of spermatogenesis and successful in vitro fertilization in an infertile male with panhypopituitarism; superiority of pulsatile LH-RH over gonadotropins? A case report.
van de Berk D; Wijnberg M; van Dop PA
Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(2):153-7. PubMed ID: 1906412
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin beta-subunit in human semen.
Saito S; Kumamoto Y; Ito N; Kurohata T
Arch Androl; 1988; 20(1):87-99. PubMed ID: 2455489
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRH--diagnosis and possible alternative treatment.
Blumenfeld Z; Frisch L; Conn PM
Fertil Steril; 1988 Oct; 50(4):622-9. PubMed ID: 3139467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
